In Norway, through our work in a general practice research committee under the Norwegian Medical Association, we have been involved in a voluntary arrangement with pharmaceutical companies where we evaluate research projects initiated by the industry and recruit general practitioners to find patients.1 Our committee makes recommendations to Norwegian general practitioners about whether a project is a real research project rather than marketing camouflaged as research.

However, after we criticised some projects …